Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark

Showing results (1331-1340 of 1,377) with videos related to

Pageof 138
Sort By:
The New England Journal of Medicine|April 1, 2020
Management of Coronary Disease in Patients with Advanced Kidney DiseaseSripal Bangalore, David J Maron, Sean M O'Brien, et al.
American Heart Journal|June 2, 2007
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policyGillian D Sanders, Sana M Al-Khatib, Elise Berliner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunitiesCornelia Laule, Julien Cohen-Adad, Atlee A Witt, et al.
JAMA|August 14, 2024
Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical TrialGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
British Journal of Pharmacology|May 21, 2024
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I studyNoboru Kaneko, Christopher M Loughrey, Godfrey Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2025
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillationNoboru Kaneko, Godfrey L Smith, Christopher M Loughrey, et al.
Circulation|July 20, 2023
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesSalim S Virani, L Kristin Newby, Suzanne V Arnold, et al.
Journal of the American College of Cardiology|March 26, 2025
Invasive vs Conservative Management of Patients With Chronic Total Occlusion: Results From the ISCHEMIA TrialSripal Bangalore, G B John Mancini, Jonathan Leipsic, et al.
Circulation|November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
American Journal of Ophthalmology|July 29, 2018
Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and OutcomeJohn J Chen, Eoin P Flanagan, Jiraporn Jitprapaikulsan, et al.
Pageof 138

Showing results (1331-1340 of 1,377) with videos related to

Sort By:
Pageof 138
The New England Journal of Medicine|April 1, 2020
Management of Coronary Disease in Patients with Advanced Kidney DiseaseSripal Bangalore, David J Maron, Sean M O'Brien, et al.
American Heart Journal|June 2, 2007
Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policyGillian D Sanders, Sana M Al-Khatib, Elise Berliner, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2026
Spinal cord imaging for multiple sclerosis: Advances, priorities, and opportunitiesCornelia Laule, Julien Cohen-Adad, Atlee A Witt, et al.
JAMA|August 14, 2024
Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical TrialGervasio A Lamas, Kevin J Anstrom, Ana Navas-Acien, et al.
British Journal of Pharmacology|May 21, 2024
A novel ryanodine receptor 2 inhibitor, M201-A, enhances natriuresis, renal function and lusi-inotropic actions: Preclinical and phase I studyNoboru Kaneko, Christopher M Loughrey, Godfrey Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 6, 2025
Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillationNoboru Kaneko, Godfrey L Smith, Christopher M Loughrey, et al.
Circulation|July 20, 2023
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice GuidelinesSalim S Virani, L Kristin Newby, Suzanne V Arnold, et al.
Journal of the American College of Cardiology|March 26, 2025
Invasive vs Conservative Management of Patients With Chronic Total Occlusion: Results From the ISCHEMIA TrialSripal Bangalore, G B John Mancini, Jonathan Leipsic, et al.
Circulation|November 13, 2020
Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)Matthew M Y Lee, Katriona J M Brooksbank, Kirsty Wetherall, et al.
American Journal of Ophthalmology|July 29, 2018
Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and OutcomeJohn J Chen, Eoin P Flanagan, Jiraporn Jitprapaikulsan, et al.
Pageof 138